Q2 2025 Earnings Call Transcript July 24, 2025 Lazard Ltd beats earnings expectations. Reported EPS is $0.52, expectations ...

Cytokinetics stock garners strong analyst support with high growth potential. Click here to find out why the CYTK's pipeline ...

Semaglutide, a GLP-1R agonist developed by Denmark’s Novo Nordisk as Ozempic, initially for type 2 diabetes, and marketed ...

The European Medicines’ (EMA) human medicines committee (CHMP) has recommended seven novel medicines for approval at its July ...

Another FTSE 100-listed (^FTSE) giant reporting in the week ahead is pharmaceuticals company AstraZeneca (AZN.L), which has ...

Find new ideas and classic advice on strategy, innovation and leadership, for global leaders from the world's best business and management experts.